VeriMomisobutylamido thiazolyl resorcinol은 임신 중 안전한가요?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment for isobutylamido thiazolyl resorcinol (Thiamidol) was identified; clinical topical studies (0.15–0.2% formulations) report efficacy and skin tolerability but no reproductive or teratogenic findings, so default hazard/mechanism = 0. Topical use gives low but measurable exposure (clinical topical use data). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33559186/?utm_source=openai))
성분
isobutylamido thiazolyl resorcinol
알려진 위험 없음93
/100
0
Pregnancy-safe products containing isobutylamido thiazolyl resorcinol
Eucerin
Eucerin Anti-Pigment Spot Corrector
96/100
Nivea
Nivea Cellular Luminous 630 Anti-dark Circle Eye Cream
86/100
Nivea
Nivea Cellular Hyaluron Filler + Elasticity & Re-Densifying Anti Spot Treatment Serum
86/100
Nivea
Nivea Luminous 630 Spotclear Treatment
86/100
Nivea
Nivea Serum Cellular Luminous630®
86/100
Nivea
Nivea Hyaluron Cellular Filler + Elasticity Anti-Pigment Serum
86/100
Nivea
Nivea Perfect & Radiant Luminous Treatment Serum
86/100
Nivea
Nivea Cellular Luminous630 Eye Treatment
86/100
Nivea
Nivea Luminous Night
86/100
Nivea
Nivea Luminous 630 Spotclear Intensive Treatment Serum
86/100
Related ingredients
Frequently asked questions
- isobutylamido thiazolyl resorcinol은 임신 중 안전한가요?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment for isobutylamido thiazolyl resorcinol (Thiamidol) was identified; clinical topical studies (0.15–0.2% formulations) report efficacy and skin tolerability but no reproductive or teratogenic findings, so default hazard/mechanism = 0. Topical use gives low but measurable exposure (clinical topical use data). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33559186/?utm_source=openai))
- isobutylamido thiazolyl resorcinol은 모유 수유 중 안전한가요?
- No data on lactation transfer or breastmilk levels and no reproductive or developmental signals in available literature. By default hazard/mechanism = 0; topical application gives low but measurable exposure so exposure = 1 in breastfeeding context absent data. Clinical safety reports do not indicate systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33559186/?utm_source=openai))
- isobutylamido thiazolyl resorcinol은 아기 피부에 안전한가요?
- No infant-specific safety or developmental studies found. Following the scoring rules, because adult topical exposure is low but measurable (e=1) and infant skin has higher absorption, exposure for baby skin is increased by +1 to e=2. No evidence found to increase hazard or mechanism scores. Note: there are case reports of allergic contact dermatitis in adults but no infant-specific adverse reports. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/40456229/?utm_source=openai))
- VeriMom은 isobutylamido thiazolyl resorcinol을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 isobutylamido thiazolyl resorcinol을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 isobutylamido thiazolyl resorcinol 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.